Wilmington Savings Fund Society’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wilmington Savings Fund Society’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3K	Hold	55	–	–	﹤0.01%	1149
2026 Q1	$10.4K	Hold	55	–	–	﹤0.01%	1185
2025 Q4	$9.35K	Hold	55	–	–	﹤0.01%	1183
2025 Q3	$7.25K	Sell	55 -84	-60%	-$10.1K	﹤0.01%	1202
2025 Q2	$14.8K	Hold	139	–	–	﹤0.01%	1545
2025 Q1	$17.3K	Hold	139	–	–	﹤0.01%	1500
2024 Q4	$17.1K	Hold	139	–	–	﹤0.01%	1530
2024 Q3	$15.5K	Buy	+139	New	+$15.2K	﹤0.01%	1533

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Wilmington Savings Fund Society's JAZZ Position: Q2 2026 in Review

Wilmington Savings Fund Society held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 55 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

Wilmington Savings Fund Society first reported a position in JAZZ in Q3 2024 and has held it in 8 quarters since. The position peaked at $17.3K in Q1 2025. 250 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Wilmington Savings Fund Society held 55 shares of Jazz Pharmaceuticals worth $13.3K as of Q2 2026.
Wilmington Savings Fund Society left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #1149 holding.
Wilmington Savings Fund Society first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's Jazz Pharmaceuticals position peaked at $17.3K in Q1 2025.
250 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.